| A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins. |
| Prospˆ©ri MT, Ferbus D, Karczinski I, Goubin G |
| The Journal of biological chemistry. 1993 ; 268 (15) : 11050-11056. |
| PMID 8496166 |
| |
| Organization and chromosomal assignment of two human PAG gene loci: PAGA encoding a functional gene and PAGB a processed pseudogene. |
| Prospˆ©ri MT, Apiou F, Dutrillaux B, Goubin G |
| Genomics. 1994 ; 19 (2) : 236-241. |
| PMID 8188254 |
| |
| Cloning and sequence analysis of candidate human natural killer-enhancing factor genes. |
| Shau H, Butterfield LH, Chiu R, Kim A |
| Immunogenetics. 1994 ; 40 (2) : 129-134. |
| PMID 8026862 |
| |
| Identification of natural killer enhancing factor as a major antioxidant in human red blood cells. |
| Shau H, Kim A |
| Biochemical and biophysical research communications. 1994 ; 199 (1) : 83-88. |
| PMID 8123050 |
| |
| Antioxidant function of recombinant human natural killer enhancing factor. |
| Sauri H, Butterfield L, Kim A, Shau H |
| Biochemical and biophysical research communications. 1995 ; 208 (3) : 964-969. |
| PMID 7702627 |
| |
| Recombinant natural killer enhancing factor augments natural killer cytotoxicity. |
| Sauri H, Ashjian PH, Kim AT, Shau H |
| Journal of leukocyte biology. 1996 ; 59 (6) : 925-931. |
| PMID 8691079 |
| |
| The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. |
| Wen ST, Van Etten RA |
| Genes & development. 1997 ; 11 (19) : 2456-2467. |
| PMID 9334312 |
| |
| Characterization of a mammalian peroxiredoxin that contains one conserved cysteine. |
| Kang SW, Baines IC, Rhee SG |
| The Journal of biological chemistry. 1998 ; 273 (11) : 6303-6311. |
| PMID 9497358 |
| |
| The pag gene product, a physiological inhibitor of c-abl tyrosine kinase, is overexpressed in cells entering S phase and by contact with agents inducing oxidative stress. |
| Prospˆ©ri MT, Ferbus D, Rouillard D, Goubin G |
| FEBS letters. 1998 ; 423 (1) : 39-44. |
| PMID 9506838 |
| |
| Expression of the antioxidant gene NKEF in the central nervous system. |
| Sarafian TA, Huang C, Kim A, de Vellis J, Shau H |
| Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid. 1998 ; 34 (1) : 39-51. |
| PMID 9778645 |
| |
| Crystal structure of a multifunctional 2-Cys peroxiredoxin heme-binding protein 23 kDa/proliferation-associated gene product. |
| Hirotsu S, Abe Y, Okada K, Nagahara N, Hori H, Nishino T, Hakoshima T |
| Proceedings of the National Academy of Sciences of the United States of America. 1999 ; 96 (22) : 12333-12338. |
| PMID 10535922 |
| |
| Differential expression of peroxiredoxin subtypes in human brain cell types. |
| Sarafian TA, Verity MA, Vinters HV, Shih CC, Shi L, Ji XD, Dong L, Shau H |
| Journal of neuroscience research. 1999 ; 56 (2) : 206-212. |
| PMID 10494109 |
| |
| Peroxiredoxin I expression in human thyroid tumors. |
| Yanagawa T, Ishikawa T, Ishii T, Tabuchi K, Iwasa S, Bannai S, Omura K, Suzuki H, Yoshida H |
| Cancer letters. 1999 ; 145 (1-2) : 127-132. |
| PMID 10530780 |
| |
| Peroxiredoxin I (macrophage 23 kDa stress protein) is highly and widely expressed in the rat nervous system. |
| Mizusawa H, Ishii T, Bannai S |
| Neuroscience letters. 2000 ; 283 (1) : 57-60. |
| PMID 10729633 |
| |
| Peroxiredoxin I expression in oral cancer: a potential new tumor marker. |
| Yanagawa T, Iwasa S, Ishii T, Tabuchi K, Yusa H, Onizawa K, Omura K, Harada H, Suzuki H, Yoshida H |
| Cancer letters. 2000 ; 156 (1) : 27-35. |
| PMID 10840156 |
| |